Scientists Discover How To Reactivate Cancer’s Dormant “Kill Switch”
The discovery could pave the way for a groundbreaking RNA-based multi-cancer treatment. Alternative RNA splicing functions ...
MyChesCo on MSN1d
Wistar Institute Reveals Breakthrough in DNA-LNP Vaccine Technology
A new study led by scientists at The Wistar Institute, in collaboration with the University of Pennsylvania Perelman School ...
New Scientist2dOpinion
Why it would be utter madness to stop funding mRNA vaccine technology
It's not a just a revolutionary and safe vaccine technology – mRNA could help make the best and most expensive drugs in the ...
The Brighterside of News on MSN3d
Breakthrough mRNA vaccine reinvents pancreatic cancer treatment
Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...
eLife4d
Generative modeling for RNA splicing predictions and design
Alternative splicing (AS) of pre-mRNA plays a crucial role in tissue-specific gene regulation, with disease implications due to splicing defects. Predicting and manipulating AS can therefore uncover ...
Mirage News4d
B Cell Mutation Insight May Impact Vaccine Development
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells ...
Labmate Online5d
Biomarker found that predicts a cancer’s ‘aggressiveness’
Novel technology enables discovery, which could help predict tumour recurrence Researchers from the Fred Hutch Cancer Centre, ...
RNA Therapeutics Market is expected to generate a revenue of USD 22.37 Billion by 2032, Globally, at 9.4% CAGR: Verified Market Research®
Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the RNA Therapeutics ...